Showing results (141-150 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|December 1, 1994
Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor A1 alleleK Blum, E R Braverman, M J Dinardo, et al.Pharmacogenetics|December 1, 1994
A complete structure of the mouse Ah receptor geneJ Mimura, M Ema, K Sogawa, et al.Pharmacogenetics|August 1, 1994
Carbamazepine and cigarette smoking induce differentially the metabolism of codeine in manQ Y Yue, T Tomson, J SäwePharmacogenetics|June 1, 1994
Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in salivaU Fuhr, K L RostPharmacogenetics|March 5, 2002
Common allelic variants of cytochrome P4503A4 and their prevalence in different populationsJatinder K Lamba, Yvonne S Lin, Kenneth Thummel, et al.Pharmacogenetics|March 5, 2002
A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphismsLori K Mattison, Martin R Johnson, Robert B DiasioPharmacogenetics|July 31, 1998
Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamineJ A Agúndez, L Gallardo, C Martínez, et al.Pharmacogenetics|July 31, 1998
Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomasH J Lin, N M Probst-Hensch, N C Hughes, et al.Pharmacogenetics|September 10, 1998
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and CaucasiansK Droll, K Bruce-Mensah, S V Otton, et al.Pharmacogenetics|May 7, 2004
The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumonLoes E Visser, Martin van Vliet, Ron H N van Schaik, et al.Pageof 83